BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide

This publication has 10 references indexed in Scilit:

• Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials
  The Lancet, 2002
• Cancer Statistics, 2002
  CA: A Cancer Journal for Clinicians, 2002
• An Australian experience with temozolomide for the treatment of recurrent high grade gliomas
  Journal of Clinical Neuroscience, 2001
• A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
  British Journal of Cancer, 2000
• Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
  Journal of Clinical Oncology, 1999
• Outcomes and Prognostic Factors in Recurrent Glioma Patients Enrolled Onto Phase II Clinical Trials
  Journal of Clinical Oncology, 1999
• New chemotherapy options for the treatment of malignant gliomas
  Current Opinion in Oncology, 1999
• Chemotherapy for brain tumors of astrocytic and oligodendroglial lineage: The past decade and where we are heading
  Neuro-Oncology, 1999
• Response criteria for phase II studies of supratentorial malignant glioma.
  Journal of Clinical Oncology, 1990
• Reporting results of cancer treatment
  Cancer, 1981